The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone

REFERENCES

• Wiegratz I, Kutschera E, Lee J, et al. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003;67:25–32.
   PubMed Web of Science ®Google Scholar
• Aden U, Jung-Hoffmann C, Kuhl H. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception 1998;58: 75–81.
   PubMed Web of Science ®Google Scholar
• Ågren UM, Anttila M, Mäepää-Liukko K, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17ß-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. Eur J Contracept Reprod Health Care 2011;16:458–67.
   PubMed Web of Science ®Google Scholar
• Fern M, Rose D, Fern E. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet Gynecol 1978;51:541–4.
   PubMed Web of Science ®Google Scholar
• Coenen C, Thomas C, Borm G, et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception 1996;53:171–6.
   PubMed Web of Science ®Google Scholar
• Van der Vange N, Blankenstein M, Kloosterboer H, et al. Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception 1990;41:345–52.
   PubMed Web of Science ®Google Scholar
• Greco T, Graham C, Bancroft J, et al. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: A comparison of two triphasic formulations containing norgestimate and either 35 or 25 μg of ethinyl estradiol. Contraception 2007;76:8–17.
   Google Scholar
• Burger HG. Androgen production in women. Fertil Steril 2002;77(Suppl. 4):S3–S5.
   PubMed Web of Science ®Google Scholar
• Speroff L, Fritz M. Clinical gynecologic endocrinology and infertility. Philadelphia, PA: Lippincott, Williams & Wilkins 2005:515.
   Google Scholar
• Boyd RA, Zegarac EA, Posvar EL, Flack MR. Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. Contraception 2001;63:71–6.
   PubMed Web of Science ®Google Scholar
• Ågren UM, Anttila M, Mäenpää-Liukko K, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17ß-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care 2011; 16:444–57.
   PubMed Web of Science ®Google Scholar
• van Kammen E, Thijssen JHH, Rademaker B, Schwarz F. The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity. Contraception 1975;11:53–9.
   PubMed Web of Science ®Google Scholar
• Odlind V, Milson I, Persson I, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?Acta Obstet Gynecol Scand 2002;81:482–90.
   PubMed Web of Science ®Google Scholar
• Hammond GL, Langley MS, Robinson PA, et al. Serum steroid binding protein concentrations, distributions of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Fertil Steril 1984;42:44–51.
   PubMed Web of Science ®Google Scholar
• Bachmann G, Bancroft J, Braunstein G, et al. Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77:660–5.
   PubMed Web of Science ®Google Scholar
• Traish A, Guay A, Spark R, the Testosterone Therapy in Women Study Group. Are the Endocrine Society's clinical practice guidelines on androgen therapy in women misguided? A commentary. J Sex Med 2007;4:1223–35.
   PubMed Web of Science ®Google Scholar
• Arlt W, Justl H-G, Callies F, et al. Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 1998;83: 1928–34.
   PubMed Web of Science ®Google Scholar
• Meno-Tetang G, Blum R, Schwartz K, Jusko W. Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics or oral prednisone and cortisol suppression in normal women. J Clin Pharmacol 2001;41:1195–205.
   PubMed Web of Science ®Google Scholar
• Morales A, Nolan J, Nelson J, Yen S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360–7.
   PubMed Web of Science ®Google Scholar
• Legrain S, Massien C, Lahlou N, et al. Dehydroepiandrosterone replacement administration: Pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 2000;85:3208–17.
   PubMed Web of Science ®Google Scholar
• Baulieu E-E, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue. PNAS 2000;97:4279–84.
   PubMed Web of Science ®Google Scholar
• Blode H, Wuttke W, Loock W, et al. A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers. Eur J Contracept Reprod Health Care 2000;5:256–64.
   PubMedGoogle Scholar
• Duijkers I, Klipping C, Grob P, Korver T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17ß-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care 2010;15:314–25.
   PubMed Web of Science ®Google Scholar
• van der Spuy ZM, Sohnius U, Pienaar CA, Schall R. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. Contraception 1990;42:597–609.
   PubMed Web of Science ®Google Scholar